Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Clarithromycin in Multiple Myeloma Induction Therapy [Phase 2]
A Phase 2 clinical trial evaluating clarithromycin as part of induction therapy for multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan and fludarabine followed by post-transplant cyclophosphamide in patients with he…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1]
A Phase 1 study evaluating lenalidomide (Revlimid) with all-trans retinoic acid (ATRA) and dexamethasone for relapsed/refractory multiple my…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients [Phase 2, Phase 3]
This clinical trial update notes the termination of a randomized Velcade-based regimen with autologous stem cell transplantation in newly di…
-
CLINICAL_TRIALS withdrawal · 2016-09-01Clinical Trial Update: A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma [Phase 2]
Phase IIa trial evaluating sotatercept for bone mass and turnover in patients with multiple myeloma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial assessing the BRd regimen (bendamustine, lenalidomide, and dexamethasone) as second-line therapy for relapsed or refr…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer [Phase 2]
A Phase 2 efficacy study of ZD6474 (vandetanib) for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma [Phase 2]
Phase 2 clinical trial of bortezomib, dexamethasone, and doxorubicin with ALCAR in previously treated multiple myeloma completed; results po…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
This study analyzes data from the EBMT registry on patients receiving plerixafor, summarizing outcomes in lymphoma and multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Clinical trial update on biomarkers related to thrombosis in patients with newly diagnosed multiple myeloma receiving chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.
-
FDA approval · 2016-08-18FDA Approved: ZOLEDRONIC ACID — Original Application (Fresenius Kabi USA, LLC)
FDA approved an Original Application for Zoledronic acid as a generic injectable product from Fresenius Kabi USA, LLC. The approval covers i…
-
CLINICAL_TRIALS research · 2016-08-17Clinical Trial Update: Institut Paoli Calmettes Multiple Myeloma Database
This document is a clinical trial update for the Institut Paoli-Calmettes Multiple Myeloma Database, which is currently recruiting participa…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating continuous versus intermittent dosing of pomalidomide in relapsed/refractory multiple myeloma; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
This document reports the completed economic evaluation of using Plerixafor to support autologous hematopoietic stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
An early-phase study of flavopiridol (alvocidib) in patients with relapsed or refractory lymphoma or multiple myeloma; the Phase 1/2 trial w…
-
FDA approval · 2016-08-04FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
FDA approved a supplemental application for KYPROLIS (carfilzomib) submitted by Onyx Pharmaceuticals, Inc. The approval updates the drug's l…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) [Phase 3]
Phase 3 trial update for stem cell transplantation in individuals with multiple myeloma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization [NA]
This entry reports a pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization in multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma [Phase 2]
Phase 2 study of TBL 12 sea cucumber extract in patients with untreated asymptomatic myeloma; the trial was terminated and results were post…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma [Phase 3]
A Phase 3 trial comparing ibandronate with zoledronic acid for nephrotoxicity in multiple myeloma was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Phase II Study of Umbilical Cord Blood Transplantation [Phase 2]
A Phase II study of Umbilical Cord Blood Transplantation was terminated, with results posted in 2016 for diseases including leukemia, lympho…
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
This is a completed observational study conducted in Latin America evaluating participants with chronic lymphocytic leukemia, multiple myelo…